Table 3.
Concurrent VA and Non‐VA Prescription Fills among n = 5,882 Post‐9/11 Veterans Receiving Opioids, Benzodiazepines, or Non‐Benzodiazepines from the VA, 2014–2016, by Year
| Concurrent Non‐VA Prescription Drug Class* | VA Prescription Drug Class* | ||
|---|---|---|---|
| Opioids† | Benzodiazepines† | Non‐Benzodiazepines† | |
| n (%) | n (%) | n (%) | |
| 2014 | n = 2,386 | n = 927 | n = 868 |
| Opioids | 286 (12.0%) | 96 (10.4%) | 87 (10.0%) |
| Benzodiazepines | 43 (1.8%) | 55 (5.9%) | 19 (2.2%) |
| Non‐benzodiazepines | 14 (0.6%) | 9 (1.0%) | 31 (3.6%) |
| 2015 | n = 2,395 | n = 935 | n = 907 |
| Opioids | 321 (13.4%) | 103 (11.0%) | 106 (11.7%) |
| Benzodiazepines | 56 (2.3%) | 62 (6.6%) | 26 (2.9%) |
| Non‐benzodiazepines | 17 (0.7%) | 6 (0.6%) | 33 (3.6%) |
| 2016 | n = 2,306 | n = 889 | n = 911 |
| Opioids | 271 (11.8%) | 99 (11.1%) | 81 (8.9%) |
| Benzodiazepines | 42 (1.8%) | 47 (5.3%) | 17 (1.9%) |
| Non‐benzodiazepines | 11 (0.5%) | 10 (1.1%) | 26 (2.9%) |
*Categories of drug classes are not mutually exclusive across columns or rows due to receipt of multiple drug classes among some veterans.
†Bolded numbers within each column represent the number of veterans receiving VA prescription fills from the respective drug class in the specified year.
PDMP, Prescription drug monitoring program; VA, Veterans Affairs.